Free company check · Companies House, live

NRG THERAPEUTICS LTD

active
Company number 11294505
Incorporated
5 Apr 2018
Age
8 years
Company type
Private limited
Registered in
Stevenage
Active directors
8
Sector
Scientific R&D · SIC 72110
Accounts due
31 Jan 2027
Confirmation due
18 Apr 2027
Registered office
Stevenage Bioscience Catalyst, Stevenage, SG1 2FX
The full check · £9 one-off

This page is the public half. The full check adds sanctions lists (OFSI, OFAC, UN), the FCA register, Gazette and court records, disqualifications, each director's other companies and an adverse-media sweep, read into a plain-English verdict. No account; emailed in minutes.

Tero is reading the filings: share allotments, the shareholder list, the latest accounts, the disqualified-directors register…
Directors
Grant HawthorneFind on LinkedIn ↗
secretary · since 2 Dec 2022
Francesco DraettaFind on LinkedIn ↗
director · since 30 Jun 2022
American · born Nov 1984
Georgia Rose FrostFind on LinkedIn ↗
director · since 2 Feb 2026
British · born Feb 1991
Charlotte Johanna Pauline KremersFind on LinkedIn ↗
director · since 22 Aug 2025
Dutch · born Apr 1995
Neil Derek MillerFind on LinkedIn ↗
director · since 5 Apr 2018
British · born Jun 1970
Florian MuellershausenFind on LinkedIn ↗
director · since 2 Jul 2025
Swiss · born Dec 1972
director · since 30 Jun 2022
Swiss · born Nov 1968
Jonathan Rex SavidgeFind on LinkedIn ↗
director · since 6 Apr 2023
British · born Sep 1973

7 officers resigned over the company's life.

Opens a LinkedIn name search. We cannot confirm identities: check the profile mentions this company before relying on it, and if nothing comes up the person may simply not be on LinkedIn.

Control · PSC register

No active persons with significant control registered.

Holdings under 25% do not appear on this register; the cap table above (when filed) shows them.

Recent filings
RP01SH015 Aug 2026
legacy
RP01SH014 Aug 2026
legacy
PSC083 Aug 2026
notification of a person with significant control statement
PSC073 Aug 2026
cessation of a person with significant control
RP01CS0128 Jul 2026
replacement filing of confirmation statement with made up date
RP01SH0127 Jul 2026
legacy
That was the registers. Now the rest.

Tero's full due-diligence report reads the pitch deck, the market, the competition, the founders' track records and the digital footprint, cross-checked against 12+ official sources, with an adversarial pass before anything is stated.

Compiled from the Companies House public registers at the time shown; verify against the live register before acting. Register name matches are not identity confirmations. Tero is software. We are not a fund, we do not hold client money, and we do not provide investment advice or personal recommendations. Information, not tax or investment advice. Capital at risk.